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Abstract
Urine exosomes (extracellular vesicles; EVs) contain
(micro)RNA (miRNA) and protein biomarkers that are
useful for the non-invasive diagnosis of various urological
diseases. However, the urinary Tamm-Horsfall protein
(THP) complex, which forms at reduced temperatures, may
affect EV isolation and may also lead to contamination by
other molecules including microRNAs (miRNAs). There‐
fore, we compared the levels of three miRNAs within the
purified EV fraction and THP- protein-network. Urine was
collected from healthy donors and EVs were isolated by
ultracentrifugation (UC), two commercial kits or sepharose
size-exclusion chromatography (SEC). SEC enables the
separation of EVs from protein-complexes in urine. After
UC, the isolation of EV-miRNA was compared with two
commercial kits. The EV isolation efficiency was evaluated
by measuring the EV protein markers, Alix and TSG101,
CD63 by Western blotting, or miR-375, miR-204 and miR-21
by RT-qPCR. By using commercial kits, EV isolation
resulted in either low yields or dissimilar miRNA levels.
Via SEC, the EVs were separated from the protein-complex
fraction. Importantly, a different ratio was observed
between the three miRNAs in the protein fraction com‐
pared to the EV fraction. Thus, protein-complexes within
urine may influence EV-biomarker studies. Therefore, the
characterization of the isolated EV fraction is important to
obtain reproducible results.
Keywords Urine Extracellular Vesicles, Ultracentrifuga‐
tion, Tamm-Horsfall Protein, Protein-complex, MicroRNA,
Size-exclusion Chromatography
1. Introduction
Extracellular vesicles (EVs) are small spherical structures
(30-200 nm) that are composed of a lipid bilayer. Different
classes of EVs have been assigned, and definitions and
proposed nomenclature, like exosomes, microvesicles and
apoptotic bodies, have been discussed [1–3]. EVs are
actively released from cells and contain proteins and
nucleic acids that partly reflect the cellular content [4]. EVs
are involved in intercellular signalling [5,6] and can be
found in biofluids such as urine [7]. As biofluids are easily
accessible, EVs have gained wide interest as a source of
biomarkers for diagnostic or prognostic measures [8].
Urine EVs are derived from epithelial cells lining within the
urinary tract [9] and are very stable [10]. EV isolation
methods are increasingly becoming available, providing
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faster, easier and less labour intensive techniques for EV
isolation. However, these commercially available kits all
need to be evaluated and isolated fractions need to be
characterized.
For isolating urine EVs, the presence of the Tam Horsfall
protein (THP; uromodulin), which forms polymers at
lower temperatures, may decrease the EV yield. THP has
been described to trap EVs. Therefore, EVs may pellet at a
lower speed centrifugation [11]. However, it has not yet
been studied to what extent the THP-protein complex
binds free miRNAs, and how this contributes to the levels
of detected miRNAs within EVs. Therefore, we investigat‐
ed to what extent THP polymers contribute to the expres‐
sion of miRNA within EVs. Using size-exclusion
chromatography (SEC), we separated the urine protein
complexes from the EV fraction. Interestingly, the protein
complexes contained miRNAs and, of the three tested
miRNAs, we found a different relationship compared to
that within the EVs, indicative of a different biomarker
profile. Therefore, when using any type of urine EV
isolation method, the contribution of protein-complexes
when performing biomarker identification studies should
be carefully considered.
2. Methods
2.1 Urine EV Isolation
Urine was collected from healthy individuals and stored at
-80˚C. The urine EVs were isolated by differential (ul‐
tra)centrifugation (UC), as previously described [5]. To
break down the THP-polymers, dithiothreitol (200 mg/ml;
DTT) was added where indicated for 1 h at 37˚C to the THP
pellet (15,000 x g pellet), and the supernatant was used for
EV isolation by UC as, previously described [12]. For a
comparative analysis, both Norgen Biotek urine EV RNA
isolation kit (#47200, Norgen Biotek, Thorold, ON, Canada)
and Life Technologies EV isolation kit (# 4484452 Life
Technologies, Mulgrave, VIC, Australia) were used,
according to the manufacturer’s instructions. The ultra‐
structural evaluation of the urine EVs was performed by a
transmission electron microscopy (TEM), as previously
described [4].
2.2 The miRNA Expression Levels
RNA was isolated by Trizol, as previously described [4].
The miRNA expression was determined by RT-PCR,
according to the manufacturer’s instructions and as
previously described [4]. We selected miR-21, miR-204 and
miR-375 (Life Technologies, Grand Island, MY, USA;
miR-21 #000397, miR-204 #000508 and miR-375 #000564),
which were described to be present in the urine EVs.
2.3 Protein Analyses
Western blot was performed, as previously described [5].
For the measurement of CD63 protein levels, non-reduced
conditions were used. The membranes were incubated
with mouse anti-Alix (1:500; Cell Signaling), goat anti-
TSG101 (1:1000; Santa Cruz Biotechnology, USA), rabbit
anti-THP (1:1000; Santa Cruz Biotechnology) or mouse
anti-CD63-antibody (1:1000; Santa Cruz Biotechnology).
The overall protein yield was determined by Coomassie
Brilliant Blue (R-250, Merck, France) staining on the total
gels, as previously described [5].
2.4 Size Exclusion Chromatography
SEC was performed according to the protocol described by
Böing et al. [13], with small modifications. In brief, sephar‐
ose (CL-4B/2B 30 mL, GE Healthcare; Uppsala, Sweden)
was washed with PBS containing 0.32% trisodiumcitrate
(pH 7.4, 0.2 µm filtered). Subsequently, the tip of a 10 mL
plastic syringe (Becton Dickinson (BD), San Jose, CA) was
stuffed with a nylon stocking (20 denier, Hema, Amster‐
dam, the Netherlands). The syringe was stacked with 10
mL washed sepharose to create a column with a diameter
of 1.6 cm and height of 6.2 cm. The urine was centrifuged
500 x g 15 minutes and 1.5 mL of it was loaded on the
column, followed by elution with PBS/0.32% citrate (pH 7.4,
0.02 µm filtered). The eluate was collected in 26 sequential
fractions of 0.5 mL. Each fraction was stored at -80˚C until
further processing.
3. Results
3.1 Ultracentrifugation and Commercial EV Isolation Kits
As UC is very labour intensive, we determined whether
commercial EV isolation kits are easier to use improved the
EV yield. To determine the EV isolation yields using the
commercial Norgen kit and Life Technologies (LT)-kit, we
compared the expression of miR-21 and miR-375. EV
isolation using both kits was considered to be very user
friendly, fast and easy. For both kits, we slightly modified
the protocol to remove debris from the samples. We then
added one additional 15,000 x g centrifugation step, as
commonly used for UC protocols. However, after using the
Norgen kit (10 ml urine), both of the tested miRNAs were
below the detection limit (Figure 1A). The output of this kit
is a purified RNA fraction, though hardly any small RNAs
were detected. This indicates that the isolation efficacy was
very poor (Figure 1B). EVs isolation by the LT-kit resulted
in higher miRNA levels (Figure 1C) by using only 5 ml of
urine as a starting material. Increasing the volume of urine,
while not increasing the solution given by LT, did not result
in an increase in the levels of the tested miRNAs. This is
probably related to the maximum binding capacity
obtained with 5 ml urine. The miRNA levels in the EVs after
UC (in which sevenfold more urine was used) were >20
times higher compared to the LT-kit (Figure 1C). When the
EVs were isolated from the unbound fraction from the LT-
kit (supernatant) by UC, we measured the high miRNA
levels that seemed to be in relation with the total miRNA
levels that were present in the sample.
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3.2 THP Traps EVs
To determine the contribution of protein complexes to the
RNA signal, we determined the level of EV-capture within
the THP-network. Storage at reduced temperatures
activates the THP-complex formation. We determined the
effect of THP on EV isolation and compared the equal input
volumes before isolation as normalization (Figure 1D).
THP was found at comparable levels when the urine was
kept at either 4˚C or -80˚C (Figure 1D). The EV marker,
CD63, was detected in both the EV (UC) and THP-pellet
fraction (15,000 x g fraction), indicating that EVs may,
indeed, be present in both fractions (Figure 1D). However,
the EV marker, TSG101, was not detected in the THP-
fraction, which indicates that the EV number in this fraction
was low (Figure 1D). To determine the amount of EVs that
were captured in the THP network, we performed an
electron microscopy. A small fraction of EVs were trapped
in the THP-network (Figure 1E). The number of EVs in the
THP pellet was slightly increased after storage at -80˚C, as
well as the presence of THP-complexes, compared to urine
storage at 4˚C, indicating that THP reduced EV isolation to
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Figure 1. Urine extracellular vesicle isolation methods. A. Expression of miR-21 and miR-375 in urine extracellular vesicles, comparing ultracentrifugation
with Norgen kit. B. Small RNA profile of isolated extracellular vesicles after Norgen and ultracentrifugation. C. Expression of miR-21 in urine of four different
donors, comparing ultracentrifugation (ultra) to that of the Life Technologies kit (LT) and the supernatant (SN). D. Western blot showing the expression of
THP, TSG101 and CD63 in extracellular vesicles and THP fraction. E. EM pictures showing extracellular vesicles trapped within the THP-network, after storage
of 4C or -80C. Size bar = 200 nm. F. The effect of the addition of 200 mg/ml DTT to the THP-pellet on the smallRNA profile before extracellular vesicles isolation
by ultracentrifugation. G. miR-21, miR-204 and miR-375 expression levels after releasing extracellular vesicles from the THP network by the addition of DTT,
showing an increase in the expression levels. Each value represents the mean +/- SD of three donors. ** p<0,01, *p<0,05.
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a small extent (Figure 1E). After breaking down the THP
network by incubation with DTT, small RNA levels were
highly increased in the EV fraction obtained after UC
(Figure 1F), compared to normal ultracentrifugation only
(Figure 1B). The levels of miR-375, miR-204 and miR-21 in
the EVs isolated with UC, combined with DTT-breakdown
fraction, was increased by ~10 times (Figure 1G).
3.3 Size Exclusion Chromatography
Besides EVs, protein-complexes are released by a break‐
down of the THP-polymer network after adding DTT. By
single-step SEC, EVs can be separated from the protein
complexes, with urine as the starting material and without
adding denaturating chemicals to the samples [13]. Within
serum, it has been described that EVs are present in
fractions nine and 10 and proteins in fractions 16-32 [13]. In
the fractions 16-23, we observed proteins, which is in
agreement with the observations of Nieuwland et al. [13]
(Figure 2A). The exosomal marker, CD63, was observed in
fractions nine and 10, and slightly in fractions 11-13 (Figure
2B). By EM, we confirmed the presence of 100 nm sized EVs
in fraction 9 and 10 (Figure 2C), similar to observations in
human serum [13] and plasma (Pegtel et al., unpublished
data). To determine the miRNA expression levels and ratio,
we performed RT-qPCR and detected miRNAs within the
EVs, and the ratio between fractions nine, 10 and 11 were
comparable (Figure 2D). On the other hand, in the protein-
fractions, the ratio between the measured miRNAs was
different compared to the EV fraction (Figure 2D-E). This
indicates that, in urine, miRNA containing protein com‐
plexes may contain a distinctive set of biomarkers com‐
pared to those found within EVs.
4. Discussion
The results from the present study demonstrate that
polymeric-THP, which is formed at reduced temperatures
in urine, traps EVs and contains miRNAs. These protein-
complexes have a different miRNA ratio of miR-21,
miR-375 and miR-204 compared to the EV fraction. There‐
fore, when using urine EVs as a source for biomarker
identification studies, both commercial EV isolation
methods and adding reducing agents, such as DTT, should
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Figure 2. Contribution of proteins to extracellular vesicle isolations. A. Coomassie staining of the lysate of 26 fractions from size exclusion, compared to the
supernatant, purified extracellular vesicle (EVs isolated by ultracentrifugation) and THP-pellet. B. Western blot showing CD63 levels in each of the 26 fractions
from size exclusion, compared to the supernatant, purified extracellular vesicles (ultracentrifugation) and THP-pellet. C. Electron microscopy pictures of
extracellular vesicles isolated within fractions 9 and 10. D. Expression of miR-204, miR-21 and miR-375 in extracellular vesicles fractions 9-11 and protein
fractions 19-21. E. Changed ratio between miR-204 and miR-375 related to miR-21, indicating that the protein fraction contains a different subset of miRNAs
than the extracellular fraction.
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EVs are secreted vesicles that are considered potential
sources for biomarkers. Urinary EVs isolation usually
contains a two-step differential centrifugation process.
During an initial 15,000xg run, high-density membranes
and THP polymers are removed. After the second step at
100,000×g, urinary EVs are normally found in the pellet
[15]. Previously, it was demonstrated that storage at -20˚C
dramatically decreased the number of EVs [10], while long-
term storage at -80˚C or short-term storage at 4˚C resulted
in comparable EV yield [10,12], which is in agreement with
our observations. The two tested commercial kits provided
a more easy and rapid method. However, repeated testing
of the Norgen kit resulted in extreme low RNA yields.
Unfortunately, this kit does not allow the characterization
of the isolated fraction, as the output is RNA only. The kit
of Life Technologies was extremely easy and fast, though
isolation of EVs was inefficient. Furthermore, both of the
isolation kits make use of a protocol that does not include
a high-speed pre-centrifugation step (15,000 x g). There‐
fore, protein complexes are potentially also captured using
the kits tested in this study.
The presence of THP in urine may reduce EV isolation
yields. THP is a major protein component of urine [16]. THP
polymer had a rope-like structure, in agreement with the
observation of others [12,17]. Polymeric THP has been
described to entrap large amounts of EVs, which may pellet
at high speed [14], reducing EV yields. DTT can release EVs
from the THP polymeric network [10,12]. However,
monomeric THP will be present in the EV fraction
[12,18,19], potentially interfering with proteomic and RNA-
assays. We observed EVs in the THP-pellet, though,
compared to the total EV fraction, the number was rela‐
tively limited. It is most likely that miRNAs are trapped by
THP network, which contribute to the higher biomarker
signals observed in previous studies, compared to the
content in EVs. By destroying this network with a reducing
agent, EVs are released, as well as protein-complexes that
contain (micro)RNA. Therefore, THP may interfere with
measuring the expression of markers when changing EV
isolation methods. In conclusion, urine EVs are a potential
source of the identification of biomarkers. Storage of urine
and further processing may affect the biomarker profile
due to the contribution of protein-complexes that also
contain RNA. We show that the contribution of protein-
complexes in urine, such as THP, requires detailed charac‐
terization before proceeding with RNA or protein-based
marker profiles for disease detection.
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